Syndax Pharmaceuticals, Inc. SNDX
9.55 USD +0.01 (+0.10%)
At closeNov 9, 2026, 5:52 PM EST
9.53 -0.02 -0.21%
After hours · Nov 9, 5:52 PM ET
9.15 Day range 9.75
9.15 52-week range 25.59
- YTD
- -54.55%
- 1 year
- -36.50%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 172.35M | 23.68M | 0 | 0 | 139.71M | |
| 165.38M | 22.85M | 0 | 0 | 139.71M | |
| -273.08M | -339.67M | -229.95M | -151.76M | 26.22M | |
| -285.42M | -318.76M | -209.36M | -149.34M | 24.93M | |
| -3.29 | -3.72 | -2.98 | -2.46 | 0.46 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 135.03M | 154.30M | 295.61M | 74.47M | 222.08M | |
| 529.71M | 724.82M | 612.88M | 497.24M | 449.66M | |
| 465.08M | 436.69M | 58.68M | 29.79M | 41.29M | |
| 345.43M | 345.74M | 1.64M | 1.16M | 20.97M | |
| 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -322.98M | -274.90M | -160.60M | -133.68M | 29.13M | |
| 290.04M | -219.78M | 117.61M | -186.19M | -40.87M | |
| 13.68M | 353.37M | 264.13M | 172.25M | 118.46M | |
| -187.00K | 0 | 0 | 225.00K | -129.00K | |
| -19.27M | -141.31M | 221.14M | -147.61M | 106.72M |